Switch Therapeutics
Switch Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 2 tracked investors.
About Switch Therapeutics
Based in the United States, Switch Therapeutics is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Switch Therapeutics develops biomarker-gated, innovative genetic medicines to transform the treatment of central nervous system diseases using its Conditionally Activated siRNA (CASi) platform, which combines single- and double-stranded RNAs for efficient self-delivery and uptake, potent gene knockdown, and cell selectivity.
Explore Switch Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.